The FDA has recently required drug companies to provide warnings on the labels of all antidepressants because of evidence that these drugs may induce
a. suicidal ideation or behaviors in a small proportion of depressed patients at the beginning of their treatment
b. parkinsonian-like symptoms in elderly patients
c. hypertensive crises when combined with certain foods or other drugs
d. convulsions in certain patients
Question 2
Recent evidence suggests that monoamine oxidase inhibitors have the greatest efficacy in the treatment of
a. atypical depressions
b. schizophrenics
c. manic patients
d. bipolar depressives
Buccal drug administration
Using alert labels enables the medical staff to quickly identify important information such as ...
Drug Schedules
Alli, the nonprescription version of the drug orlistat, was approved by the FDA
Many hunger-relief programs work to provide food aid to needy nations
Jia's Fashions recently paid a $2 annual dividend. The company is projecting that its ...